Sarcopenia

Regular price €171.06
Quantity:
In stock with our UK publisher. 14-28 days
Delivery/Collection within 10-20 working days
14 days return policy Shipping & Delivery
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Alfonso J. Cruz-Jentoft
B01=John E. Morley
biomarkers
Category1=Non-Fiction
Category=MJ
clinal management
COP=United Kingdom
Delivery_Delivery within 10-20 working days
eq_isMigrated=2
eq_nobargain
impact on field of gerontology
Language_English
PA=Available
prevention strategies
Price_€100 and above
PS=Active
sarcopenia
softlaunch
treatment options

Product details

  • ISBN 9781119597872
  • Weight: 975g
  • Dimensions: 178 x 246mm
  • Publication Date: 29 Jul 2021
  • Publisher: John Wiley and Sons Ltd
  • Publication City/Country: GB
  • Product Form: Hardback
  • Language: English
Secure checkout Fast Shipping Easy returns
SARCOPENIA

An in-depth examination of sarcopenia’s underexplored yet widespread impact within the field of gerontology

Sarcopenia is common in older men and women, and yet awareness of its clinical relevance is still relatively low. Only formally included in the International Classification of Diseases in 2016, the condition may impact societies with serious health-related and financial consequences unless consistent, effective methods of identification and management are adopted.

This second edition of Sarcopenia provides geriatricians and other healthcare professionals with a revised and expanded examination of this understudied and underdiagnosed condition. Edited by two leading authorities on the subject, it covers the epidemiology and diagnosis of sarcopenia, as well as treatment options and possible prevention strategies. Eight newly written chapters build upon existing knowledge with fresh data on topics including sarcopenia’s biomarkers and its impact on the healthcare economy. This important text:

  • Defines sarcopenia and explains its clinical relevance
  • Covers all recent scientific evidence
  • Outlines treatment options
  • Considers prevention strategies
  • Discusses sarcopenia as a public health priority
  • Features eight new chapters covering topics such as sarcopenia’s clinical management, its biomarkers, and its financial impact

Containing vital information for clinicians and other professionals working in geriatric care, nursing homes, nutrition, cancer, endocrinology, surgery, sports medicine and many other specialties, Sarcopenia, second edition, is a groundbreaking and essential new resource.

Alfonso J. Cruz-Jentoft, MD, Professor, Geriatrics, Universidad Europea de Madrid, and Director of Geriatric Medicine, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.

John E. Morley, MD, Professor, Geriatrics, St Louis University Medical School, St Louis, MO, USA.